Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 506 entries
View as:

An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00811564 Org: User:
Start: 12/31/08 End: 01/31/10 Due: 01/31/11

Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)

Phase: N/A Priority: Normal
NCT ID: NCT01568021 Org: User:
Start: 10/31/11 End: 11/30/13 Due: 11/30/14

A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Phase: N/A Priority: Normal
NCT ID: NCT01628614 Org: User:
Start: 11/30/10 End: 07/31/11 Due: 07/31/12

Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia

Phase: N/A Priority: Normal
NCT ID: NCT00528541 Org: User:
Start: 09/30/07 End: 09/30/09 Due: 09/30/10

BOTOX® Prophylaxis in Patients With Chronic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT01432379 Org: User:
Start: 09/09/11 End: 05/12/15 Due: 05/12/16

JUVÉDERM® VOLITE™ XC for Cheek Skin Smoothness

Phase: N/A Priority: Normal
NCT ID: NCT03728309 Org: User:
Start: 11/09/18 End: 07/17/20 Due: 07/17/21

A Study of Hyaluronic Acid Injectable Gel (VYC-25L) for Restoration and Creation of Facial Volume in the Chin and Jaw

Phase: N/A Priority: Normal
NCT ID: NCT02559908 Org: User:
Start: 02/26/15 End: 12/01/17 Due: 12/01/18

A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia

Phase: N/A Priority: Normal
NCT ID: NCT00168441 Org: User:
Start: 06/30/04 End: 06/30/05 Due: 06/30/06

Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00445705 Org: User:
Start: 03/31/07 End: 01/31/08 Due: 01/31/09

A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02020512 Org: User:
Start: 07/31/11 End: 12/31/12 Due: 12/31/13

A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01886690 Org: User:
Start: 08/20/13 End: 08/18/14 Due: 08/18/15

Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01216943 Org: User:
Start: 11/30/10 End: 08/31/12 Due: 08/31/13

Safety and Effectiveness of the XEN45 Glaucoma Treatment System in Patients With Angle Closure Glaucoma

Phase: N/A Priority: Normal
NCT ID: NCT03362931 Org: User:
Start: 07/19/18 End: 03/18/22 Due: 03/18/23

Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

Phase: N/A Priority: Normal
NCT ID: NCT02176356 Org: User:
Start: 06/30/14 End: 05/03/15 Due: 05/03/16

Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Phase: N/A Priority: Normal
NCT ID: NCT01628588 Org: User:
Start: 03/31/10 End: 12/31/10 Due: 12/31/11

Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01157364 Org: User:
Start: 09/23/10 End: 08/09/16 Due: 08/09/17

Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence

Phase: N/A Priority: Normal
NCT ID: NCT01064882 Org: User:
Start: 03/31/10 End: 07/31/10 Due: 07/31/11

Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT00884585 Org: User:
Start: 05/31/09 End: 07/31/11 Due: 07/31/12

Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00652483 Org: User:
Start: 05/31/03 End: 09/30/04 Due: 09/30/05

Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion

Phase: N/A Priority: Normal
NCT ID: NCT01618266 Org: User:
Start: 11/30/11 End: 10/31/14 Due: 10/31/15

An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes

Phase: N/A Priority: Normal
NCT ID: NCT01623479 Org: User:
Start: 11/19/10 End: 09/01/11 Due: 09/01/12

Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT01459588 Org: User:
Start: 10/01/11 End: 02/15/12 Due: 02/15/13

A Study to Compare a New Eye Drop Formulation With Refresh Contacts®

Phase: N/A Priority: Normal
NCT ID: NCT01844388 Org: User:
Start: 05/29/13 End: 12/02/13 Due: 12/02/14

A Safety and Effectiveness of VOLBELLA XC Hyaluronic Acid (HA) Injectable Gel to Correct Infraorbital Hollowing

Phase: N/A Priority: Normal
NCT ID: NCT03418545 Org: User:
Start: 01/26/18 End: 08/22/19 Due: 08/22/20

AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00325715 Org: User:
Start: 04/30/06 End: 08/31/06 Due: 08/31/07